Literature DB >> 21460713

Hyperbaric oxygen in the critically ill.

Lindell K Weaver1.   

Abstract

OBJECTIVE: To review aspects of hyperbaric medicine pertinent to treating critically ill patients with hyperbaric oxygen in both monoplace and multiplace chambers. DATA SOURCES: Literature review of online databases, research repositories, and clinical trial registries.
RESULTS: The search of these resources produced information regarding technical considerations, feasibility, risk, and patient management. Hyperbaric oxygen is used in treating a number of disorders that occur in critically ill patients, including acute carbon monoxide poisoning, arterial gas embolism, severe decompression sickness, clostridial gas gangrene, necrotizing fasciitis, and acute crush injury. Most chambers in the United States treat outpatients with problem nonhealing wounds, and many chambers are not hospital-based. Only a few hyperbaric medicine centers have intensive care unit-level staffing, specialized equipment, a 24/7 schedule, and experience in treating critically ill patients. Not all intensive care unit-related equipment can be subjected to hyperbaric pressurization, and some equipment may increase the risk for fire inside the chamber.
CONCLUSIONS: Treating critically ill patients with hyperbaric oxygen requires specialized equipment and personnel with intensive care unit skills and knowledge of the physiology and risks unique to hyperbaric oxygen exposure. Like with all medical interventions, it is important to consider the risk vs. the benefit of hyperbaric oxygen for any given critical care disorder, but hyperbaric oxygen can be delivered safely to critically ill patients. Many critical care environments without present hyperbaric oxygen capability may wish to consider offering hyperbaric oxygen to patients with hyperbaric oxygen-approved indications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460713     DOI: 10.1097/CCM.0b013e31821858d1

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample.

Authors:  Chai R Soh; Ricardo Pietrobon; John J Freiberger; Sophia T Chew; Dimple Rajgor; Mihir Gandhi; Jatin Shah; Richard E Moon
Journal:  Intensive Care Med       Date:  2012-04-20       Impact factor: 17.440

2.  Bench testing of a new hyperbaric chamber ventilator at different atmospheric pressures.

Authors:  Jean-Claude Lefebvre; Aissam Lyazidi; Miguel Parceiro; Giuseppe F Sferrazza Papa; Evangelia Akoumianaki; Deborah Pugin; Didier Tassaux; Laurent Brochard; Jean-Christophe M Richard
Journal:  Intensive Care Med       Date:  2012-05-17       Impact factor: 17.440

3.  Clinical Outcomes and Mortality Impact of Hyperbaric Oxygen Therapy in Patients With Carbon Monoxide Poisoning.

Authors:  Jason J Rose; Mehdi Nouraie; Marc C Gauthier; Anthony F Pizon; Melissa I Saul; Michael P Donahoe; Mark T Gladwin
Journal:  Crit Care Med       Date:  2018-07       Impact factor: 7.598

4.  Performance of the BBraun perfusor space syringe driver under hyperbaric conditions.

Authors:  Lachlan Frawley; Bridget Devaney; Theo Tsouras; Geoff Frawley
Journal:  Diving Hyperb Med       Date:  2017-03       Impact factor: 0.887

5.  Early hyperbaric oxygen therapy improves survival in a model of severe sepsis.

Authors:  Jonathan L Halbach; James M Prieto; Andrew W Wang; Dennis Hawisher; David M Cauvi; Tony Reyes; Jonathan Okerblom; Israel Ramirez-Sanchez; Francisco Villarreal; Hemal H Patel; Stephen W Bickler; George A Perdrizet; Antonio De Maio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-15       Impact factor: 3.619

6.  Pulmonary Phototherapy for Treating Carbon Monoxide Poisoning.

Authors:  Luca Zazzeron; Chen Liu; Walfre Franco; Akito Nakagawa; William A Farinelli; Donald B Bloch; R Rox Anderson; Warren M Zapol
Journal:  Am J Respir Crit Care Med       Date:  2015-11-15       Impact factor: 21.405

7.  Oxygen toxicity seizures during United States Navy Treatment Table 6: An acceptable risk in monoplace chambers?

Authors:  Samantha Bonnington; Neil Banham; Kevin Foley; Ian Gawthrope
Journal:  Diving Hyperb Med       Date:  2021-06-30       Impact factor: 1.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.